[Polychemotherapy of cancer. Preliminary study concerning 82 cases, of which 76 are cases of cancer of stomatologic origin].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008441:Maxillary Neoplasms / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006834:Hydrazines; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
Polychimiothérapie des cancers. Etude préliminaire portant sur 82 cas, dont 76 observations de cancers d'origine stomatologique.